Role of sublingual asenapine in treatment of schizophrenia
Leslie CitromeNew York University School of Medicine, Department of Psychiatry, New York, NY, USAAbstract: Asenapine tablets are a new option for the treatment of schizophrenia. Sublingual administration is essential because bioavailability if ingested is less than 2%. Efficacy is supported by acute...
Saved in:
Main Author: | Citrome L |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/589f49acb84f4d5fa42f9e3e44a0e5f2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
by: Warren CG, et al.
Published: (2013) -
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
by: Delia Bishara, et al.
Published: (2009) -
The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
by: Pompili M, et al.
Published: (2011) -
Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
by: Gao K, et al.
Published: (2013) -
Role of aripiprazole in treatment-resistant schizophrenia
by: Mossaheb N, et al.
Published: (2012)